ALGORITHM OF TREATMENT APPROACHES IN MEDIASTINAL NON-CHROMAFFIN PARAGANGLIOMAS


Cite item

Full Text

Abstract

The results of different methods of radical and palliative treatment in 26 patients with intrathoracic localization of nehromafinnoy paraganglioma, 24 tumors were located in the front, one - in the posterior mediastinum, and one - in the pericardial cavity. Malignant paragangioma was confirmed morphologically in 25 observed patients. Surgical intervention is undertaken in 17 patients, of whom 12 had surgery as an integral stage of complex or combined treatment, in 3 - self-treatment and 2 - exeprimental thoracotomy. Combined treatment including preoperative radiotherapy (RT) followed by surgery was undertaken by 6 patients. Comprehensive treatment including neoadjuvant chemotherapy (CT) was received by 6 patients and in combination with radiotherapy by 3 patients. In 5 of these patients the technique of regional intra-arterial administration of anticancer chemotherapy was used. Patients with the presence of distant metastases performed palliative treatment: 4 - LT, 5 - HT. Conclusion: for the radical treatment of malignant paraganglioma method of choice should be a comprehensive treatment with neoadjuvant intra-arterial regional chemotherapy.

About the authors

V. D Zakharychev

P.L.Shupik National Medical Academy of Postgraduate Education

Email: vusal_sh@mail.ru
д-р мед. наук, проф., проф. каф. онкологии 04112, Kiev, Ukraine

M. S Krotevitch

National Cancer Institute

03022, Kiev, Ukraine

References

  1. Захарычев В.Д., Ганул А.В., Галахин К.А. и др. Внутригрудные нехромаффинные параганглиомы (хемодектомы). Онкология. 2005; 7 (1): 79-85.
  2. Кармазовский Г.Г., Коростелев А.Н., Дубова Е.А., Туманова У.Н. Параганглиома сердца. Хирургия. 2011; 1: 61-4.
  3. Седых С.А., Тепляков В.В., Епифанов С.В. и др. Диагностика и лечение злокачественной параганглиомы подвздошнопаховой области. Сибирский онкологический журнал. 2009; 36 (6): 78-82.
  4. Cha R., Rainear K., Paczolt E., Mahapatro D. Cardiac paraganglioma in New Jersey. N. J. Med. 1997; 94(7): 35-7.
  5. Shapiro B., Gonzales E., Weissman A. et al. Malignant paraganglioma of the prostate: case report, depiction by meta iodobenzylguanidine scintigraphy and review of the literature. J. Nucl. Med. 1997; 41(1): 36-41.
  6. Shono T., Sakai H., Minami Y. et al. Paraganglioma of urinary bladder: a case report and review of the Japanese literature. Urol. Int. 1999; 62 (2): 102-5.
  7. Stanulla H. Intrathoracal nonchromaffin paragangliomas (chemodectomas) (author’s transl). Zbl. Allg. Pathol. 1982; 126 (1- 2): 151-6.
  8. Baysal B.E., Farr J.E., Rubinstein W.S. et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q22. Am. J. Hum. Genet. 1997; Jan 60(1): 121-32.
  9. Brown M.L., Zayas G.E., Abel M.D, et al. Mediastinal paragangliomas: The Mayo clinic experience. Ann. Thorac. Surg. 2008; 86: 946-51.
  10. Hoffmann J., Krober S.M., Hahn U. et al. Polytopic manifestations of paragangliomas. Diagnosis, differential diagnosis and indications for therapy. Cancer. 1997; 79(2): 398-402.
  11. Rao A.B., Koeller K.K., Adair C.F. Paragangliomas of the head and neck: radiologic-pathalogic correlation. Radiographics. 1999; 19: 1605-32.
  12. Perel Y., Schlumberger M., Marguerite G. et al. Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric Oncology. Pediatr Hematol. Oncol. 1997; 14(5): 413-22.
  13. Дедков И.П., Захарычев В.Д. Первичные новообразования средостения. Киев, Здоров’я, 1982.
  14. Mancini L., Roncaroli F. Malignant paraganglioma of the posterior mediastinum with 27 years follow-up. Pathologica. 1997; 98 (2): 184-8.
  15. Tomita H., Yamashita H., Tamaki N. Malignant paraganglioma with intracranial metastasis: a case report. No Shinkei Geka. 1996; 24(11): 1045-8.
  16. Kimura S., Iwai M., Fukuda T. et al. Combination chemotherapy for malignant paragangliom. Intern. Med. 1997; 36 (1): 35-9.
  17. Liu Q., Djuricin G., Staren E.D., et al. Tumor angiogenesis in pheochromocytomas and paragangliomas. Surgery. 1996; 120(6): 938-42.
  18. Ilias I., Pecack K. Current approaches and recommended algoritm for the diagnostic localization of pheochromacytoma. J. Clin Endocrinol. 2004; 89 (2): 479-91.
  19. Maurea S., Cuocolo A., Reynolds J.C. et al. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. J. Nucl. Med. 1996; 40(4): 365-71.
  20. Wald O., Shapira O.M., Murar A., Ishar U. Paraganglioma of the mediastinum: challenges in diagnosis and surgical management. J. Cardiovasc. Surg. 2010; 5: 19-23.
  21. Rana R.S., Dey P., Das A. Fine needle aspiration cytology of extra-adrenal paragangliomas. Cytopathology. 1997; 8(2): 108-13.
  22. Andrade C.F., Сamargo S.M., Zachet M. et al. Nonfuncioning paraganglioma of the aortopulmonary window. Ann. Thorac. Surg. 2003; 75 (6): 1950-1.
  23. Williams K.S., Temeck B.K., Pass H.I. Intrapericardial pheochromacytoma complicated by massive intraoperativ hemorrhage. Southern Med. J. 1994; 87 (11): 1164-7.
  24. Argiris A., Mellot A., Spies S. PET scan assessment of chemotherapy response in metastatic paraganglioma. Am. J. Clin. Oncol. 2003; 26 (6): 563-6.
  25. Huang H., Abraham J., Hung E. et al. Treatment of malignant pheochromacytoma/paraganglioma with ciclophosphamide, vincristine and dacarbazine/ recommendation from a 22-year follow-up of 18 patients. Cancer. 2008; 113 (8): 2020-8.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies